Interstitial Lung Disease, Lung Cancer, Sarcoidosis, Tuberculosis
Conditions
Keywords
bronchoscopy, lignocaine, cough
Brief summary
Flexible bronchoscopy is a common procedure performed by pulmonary physicians. The use of topical anesthesia, analgesia, and sedation during flexible bronchoscopy varies among physicians, institutions and geographic locations across the globe. Commonly used topical anesthetic agents before and during bronchoscopy include cocaine (4%),benzocaine (20%), tetracaine (1%), and lignocaine (1%-10%). Topical lignocaine is administered through the flexible bronchoscope in an attempt to reduce excessive coughing and patient discomfort. However, the optimal dosage and strength of topical lignocaine that should be used during fibreoptic bronchoscopy has long been a topic of controversy. In this study we compare the efficacy of 1% versus 2% lignocaine in controlling cough and pain in patients undergoing flexible bronchoscopy.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Consecutive patients undergoing flexible bronchoscopy * Hemodynamic stability
Exclusion criteria
* Patients receiving sedatives during the course of their treatment * Patients undergoing conventional TBNA and/or EBUS-TBNA who are likely to receive sedation * Patients with known hypersensitivity to lignocaine * Not willing to provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Cough suppression (by Operator and Patient) | 15 minutes | Cough will be rated on a visual analog scale (VAS) from 0 (no cough) to 100 mm (worst cough ever) |
| Pain control | 15 minutes | Pain will be assessed on Wong Baker Face rating scale |
Countries
India